A case of IgG4-related sclerosing mesenteritis

Pathology Research and Practice

Volumn 207, Issue 8, 2011, Pages 518-521

  Nomura, Yoriko ^a,b   Naito, Yoshiki ^a,b,c   Eriguchi, Naofumi ^c   Kume, Toru ^d   Itai, Noriaki ^c   Sonoda, Hirokuni ^c   Hayashida, Shigeru ^c   Naito, Shigetoshi ^c   Naito, Hisanori ^c   Yasumoto, Makiko ^b   Akiba, Jun ^b   Kinoshita, Hisafumi ^b   Yano, Hirohisa ^b   Kage, Masayoshi ^a  

^a KURUME UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Naito Hospital   (Japan)

^d FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IgG4; Inflammatory pseudotumor; Obstructive phlebitis; Sclerosing mesenteritis

Indexed keywords

C REACTIVE PROTEIN; CD20 ANTIGEN; CD3 ANTIGEN; CD79A ANTIGEN; IMMUNOGLOBULIN G4;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEOCECETOMY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; LYMPHOCYTIC INFILTRATION; MESENTERITIS; MICROSCOPY; PLASMA CELL; SMALL INTESTINE RESECTION; SMALL INTESTINE TUMOR; TUMOR VOLUME;

AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; PANNICULITIS, PERITONEAL;

EID: 80051802025     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.05.009     Document Type: Article

References (24)

1. Chen T.S., Montgomery E.A. Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders?. J. Clin. Pathol. 2008, 61:1093-1097.
2. Kamisawa T. IgG4-related sclerosing disease. Intern. Med. 2006, 45:125-126.
3. Sakata N., Tashiro T., Uesugi N., et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am. J. Surg. Pathol. 2008, 32:553-559.
4. Kornprat P., Liegl-Atzwanger B., Portugaller H., Bernhardt G.A., Mischinger H.J. Sclerosing mesenteritis, a rare cause of a retroperitoneal tumor. Wien Klin Wochenschr. 2010, 122:179-183.
5. Duerloo E.E., Peterse J.L., Pruijt J.F., Kool L.J., Quiz case. Mesenteric panniculitis (sclerosing mesenteritis mesenteric lipodystrophy retractile or liposclerotic mesenteritis). Eur. J. Radiol. 2001, 38:160-162.
6. Belghiti H., Cazals-Hatem D., Couvelard A., Guedj N., Bedossa P. Sclerosing mesenteritis: can it be a IgG4 dysimmune disease?. Ann. Pathol. 2009, 29:468-474.
7. Zen Y., Kitagawa S., Minato H., et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum. Pathol. 2005, 36:710-717.
8. Ishida M., Hotta M., Kushima R., Shibayama M., Shimizu T., Okabe H. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol. Int. 2009, 59:670-675.
9. Joo M., Chang S.H., Kim H., Lee K.C., Ro J.Y. Idiopathic segmental ureteritis, misdiagnosed as ureteral cancer preoperatively: a case report with literature review. Pathol. Int. 2010, 60:779-783.
10. Kamisawa T., Okamoto A. IgG4-related sclerosing disease. World J. Gastroenterol. 2008, 14:3948-3955.
11. Kamisawa T., Funata N., Hayashi Y., et al. A new clinicopathological entity of IgG4-related autoimmune disease. J. Gastroenterol. 2003, 38:982-984.
12. Tabata T., Kamisawa T., Takuma K., et al. Serum IgG4 concentrations and IgG4-related sclerosing disease. Clin. Chim. Acta 2009, 408:25-28.
13. Daskalogiannaki M., Voloudaki A., Prassopoulos P., et al. CT evaluation of mesenteric panniculitis: prevalence and associated diseases. AJR Am. J. Roentgenol. 2000, 174:427-431.
14. Yamamoto H., Yamaguchi H., Aishima S., et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am. J. Surg. Pathol. 2009, 33:1330-1340.
15. Bridge J.A., Kanamori M., Ma Z., et al. Fusion of the ALK gene to the clathrin heavy chain gene CLTC, in inflammatory myofibroblastic tumor. Am. J. Pathol. 2001, 159:411-415.
16. Chan J.K., Cheuk W., Shimizu M. Anaplastic lymphoma kinase expression in inflammatory pseudotumors. Am. J. Surg. Pathol. 2001, 25:761-768.
17. Griffin C.A., Hawkins A.L., Dvorak C., Henkle C., Ellingham T., Perlman E.J. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res. 1999, 59:2776-2780.
18. Lawrence B., Perez-Atayde A., Hibbard M.K., et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am. J. Pathol. 2000, 157:377-384.
19. Yamamoto H., Kohashi K., Oda Y., et al. Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene. Pathol. Int. 2006, 56:584-590.
20. Dehner L.P., Coffin C.M. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin. Diagn. Pathol. 1998, 15:161-173.
21. Kamisawa T., Shimosegawa T., Okazaki K., et al. Standard steroid treatment for autoimmune pancreatitis. Gut 2009, 58:1504-1507.
22. Bala A., Coderre S.P., Johnson D.R., Nayak V. Treatment of sclerosing mesenteritis with corticosteroids and azathioprine. Can. J. Gastroenterol. 2001, 15:533-535.
23. Khosroshahi A., Bloch D.B., Deshpande V., Stone J.H. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010, 62:1755-1762.
24. Akram S., Pardi D.S., Schaffner J.A., Smyrk T.C. Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients. Clin. Gastroenterol. Hepatol. 2007, 5:589-596. 23-24; quiz.